Cookies help us improve your website experience.
By using our website, you agree to our use of cookies.
By using our website, you agree to our use of cookies.
中文 
English
最新的帖子
十月 10, 2019
New FDA Guidance on “Considerations in Demonstrating Interchangeability with a Reference Product” – How West is Working to Support Biosimilar Companies
The development of new biosimilar products has increased over the past several years. Europe and Asia Pacific have been leading the industry with the greatest number of biosimilars being introduced to the market. Given the demand to reduce medical costs for patients, this trend is expected to increase globally in the coming years.
以前的博客
